Search

everythinglearnresearchcommunity

for

Search:↓

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Hair loss needs more research for better treatments.

Minoxidil sulfate stimulates hair growth.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Finasteride effectively treats hidradenitis suppurativa for most patients.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Neurosteroids show promise for treating epilepsy and more research is needed.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Applying a specific inhibitor lightens skin and hair color.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.